Comparative assessment of sunitinib-associated adverse events (AES) as potential biomarkers of efficacy in metastatic renal cell carcinoma (mRCC) Meeting Abstract


Authors: Donskov, F.; Michaelson, M. D.; Puzanov, I.; Davis, M. P.; Bjarnason, G. A.; Motzer, R. J.; Lin, X.; Cohen, D. P.; Wiltshire, R.; Rini, B. I.
Abstract Title: Comparative assessment of sunitinib-associated adverse events (AES) as potential biomarkers of efficacy in metastatic renal cell carcinoma (mRCC)
Meeting Title: 37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 9
Meeting Dates: 2012 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-09-01
Start Page: ix259
Language: English
ACCESSION: WOS:000309409001267
PROVIDER: wos
PUBMED: 23012731
DOI: 10.1093/annonc/mds399
Notes: Meeting Abstract: 785O -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer